TIMP3 and kidney disorder: Loss of TIMP3, the only known physiological inhibitors of ADAM17, is associated with age-related renal fibrosis and tubulointerstitial fibrosis (Kawamoto et al, 2006; Kassiri et al, 2009), which are important prognostic marker in a wide variety of kidney diseases.